Martin Hibbs

2.1k total citations
25 papers, 1.0k citations indexed

About

Martin Hibbs is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Martin Hibbs has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Martin Hibbs's work include Protease and Inhibitor Mechanisms (7 papers), RNA and protein synthesis mechanisms (6 papers) and Genomics and Phylogenetic Studies (4 papers). Martin Hibbs is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), RNA and protein synthesis mechanisms (6 papers) and Genomics and Phylogenetic Studies (4 papers). Martin Hibbs collaborates with scholars based in United Kingdom, United States and Australia. Martin Hibbs's co-authors include Andrew Fosberry, B. Paul Morgan, Sara J. Piddlesden, Maria K. Storch, Hans Lassmann, Richard L. Jarvest, Richard A. Smith, Richard Smith, John M. Berge and Peter J. O’Hanlon and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Biochemistry.

In The Last Decade

Martin Hibbs

25 papers receiving 1.0k citations

Peers

Countries citing papers authored by Martin Hibbs

Since Specialization

Citations

This map shows the geographic impact of Martin Hibbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Hibbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Hibbs more than expected).

Fields of papers citing papers by Martin Hibbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Hibbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Hibbs. The network helps show where Martin Hibbs may publish in the future.

Co-authorship network of co-authors of Martin Hibbs

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Hibbs. A scholar is included among the top collaborators of Martin Hibbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Hibbs. Martin Hibbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Crystallization and initial crystallographic analysis of covalent DNA-cleavage complexes of Staphyloccocus aureus DNA gyrase with QPT-1, moxifloxacin and etoposide 2015 ·Acta Crystallographica Section F Structural Biology Communications ·Srikannathasan Velupillai, Alexandre Wohlkönig, Anthony Shillings, Onkar Singh, Pan F. Chan, Jianzhong Huang, Michael N. Gwynn, Andrew Fosberry, Paul Homes, Martin Hibbs, (unknown), Claus Spitzfaden, B.D. Bax	16
2	Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin 2015 ·Nature Communications ·Pan F. Chan, Srikannathasan Velupillai, Jianzhong Huang, Haifeng Cui, Andrew Fosberry, Minghua Gu, Michael M. Hann, Martin Hibbs, Paul Homes, Karen Ingraham, (unknown), (unknown), Anthony Shillings, Claus Spitzfaden, Robert D. Tanner, (unknown), Robert A. Stavenger, B.D. Bax, Michael N. Gwynn	122
3	Discovery and Biochemical Characterization of Plasmodium Thioredoxin Reductase Inhibitors from an Antimalarial Set 2012 ·Biochemistry ·(unknown), (unknown), (unknown), Gonzalo Colmenarejo, (unknown), Francisco‐Javier Gamo, Martin Hibbs, (unknown), Daniel A. Thomas	17
4	High-yield production and characterization of biologically active GST-tagged human topoisomerase IIα protein in insect cells for the development of a high-throughput assay 2010 ·Protein Expression and Purification ·Praveen Kumar Singh, Pan F. Chan, Martin Hibbs, (unknown), (unknown), Daniel A. Thomas, (unknown), Kathleen T. Gallagher, Namir J. Hassan	13
5	Development of an insect-cell-based assay for detection of kinase inhibition using NF-κB-inducing kinase as a paradigm 2008 ·Biochemical Journal ·Namir J. Hassan, Sheraz Gul, Fiona Flett, (unknown), (unknown), Amanda Emmons, Jonathan P. Hutchinson, Martin Hibbs, (unknown), Jeremy Kitson, (unknown), Martin Rüdiger, David G. Tew, (unknown), Mary A. Morse	6
6	Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase 2005 ·Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, Symon G. Erskine, Andrew K. Forrest, Andrew Fosberry, Martin Hibbs, (unknown), Peter J. O’Hanlon, Robert J. Sheppard, Angela Worby	19
7	Design and synthesis of conformationally restricted eight-Membered ring diketones as potential serine protease inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Neil D. Pearson, Drake S. Eggleston, R. Curtis Haltiwanger, Martin Hibbs, (unknown), Arun C. Kaura	6
8	Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens 2002 ·Journal of Medicinal Chemistry ·Richard L. Jarvest, John M. Berge, Valerie Berry, Helen Boyd, Murray J. B. Brown, (unknown), Andrew K. Forrest, Andrew Fosberry, Daniel R. Gentry, Martin Hibbs, Deborah D. Jaworski, Peter J. O’Hanlon, Andrew J. Pope, Stephen Rittenhouse, Robert J. Sheppard, (unknown), Angela Worby	92
9	Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors 2001 ·Protein Science ·Xiayang Qiu, Cheryl A. Janson, Ward W. Smith, Susan M. Green, Patrick McDevitt, Kyung Johanson, Paul Carter, Martin Hibbs, Ceri Lewis, Alison F. Chalker, Andrew Fosberry, Judith M. LaLonde, John M. Berge, Pamela Brown, C. S. V. HOUGE‐FRYDRYCH, Richard L. Jarvest	166
10	Identification, Cloning, and Expression of a Functional Phenylalanyl-tRNA Synthetase (pheRS) from Staphylococcus aureus 2001 ·Protein Expression and Purification ·(unknown), Martin Hibbs, Emma J. Jones, Lucy Mensah, Christine M. Richardson, Andrew Fosberry, (unknown), (unknown), James R. Brown, Owen Jenkins	6
11	Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and l-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass 1996 ·Journal of Thoracic and Cardiovascular Surgery ·Adam Finn, B. Paul Morgan, (unknown), Nigel Klein, Catherine A. Rogers, Martin Hibbs, Martin J. Elliott, (unknown), Timothy W. Evans, Stephan Ströbel, Neil Moat	42
12	Effects of inhibition of complement activation using recombinant soluble CR1 on neutrophil CD1 1b/CD18 and L-selectin expression and release of IL8 and elastase in simulated cardiopulmonary bypass 1996 ·Journal of Thoracic and Cardiovascular Surgery ·Adam Finn, B. Paul Morgan, (unknown), Nigel Klein, CA Rogers, Martin Hibbs, Michael Elliott, (unknown), Timothy W. Evans, S. Strobel, Neil Moat	1
13	Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. 1996 ·PubMed ·Julian R. Pratt, Martin Hibbs, (unknown), Richard Smith, Steven H. Sacks	73
14	Activation of complement by DMSO and ethanol and its inhibition by soluble complement receptor type 1 1995 ·Biochemical Society Transactions ·(unknown), Martin Hibbs, Richard A. Smith	5
15	Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. 1994 ·The Journal of Immunology ·Sara J. Piddlesden, Maria K. Storch, Martin Hibbs, (unknown), Hans Lassmann, B. Paul Morgan	171
16	Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730) 1993 ·European Journal of Pharmacology ·Edward F. Smith, D.E. Griswold, John Egan, Leonard M. Hillegass, Richard Smith, Martin Hibbs, Robert Gagnon	38
17	146 Synthesis and fibrinolytic properties of a conjugate of urokinase with the active centre of human plasmin 1988 ·Fibrinolysis and Proteolysis ·H. Ferres, Robert Cassels, Robin Fears, (unknown), Martin Hibbs, S. Barret Kalindjian, Richard A. Smith	2
18	Deacylation Studies in Vitro on Anisoylated Plasminogen Streptokinase Activator Complex 1987 ·Drugs ·H. Ferres, Martin Hibbs, Richard A. Smith	14
19	Consequences of Antibody Binding in Vitro on the Pharmacological Properties of Anisoylated Plasminogen Streptokinase Activator Complex 1987 ·Drugs ·Robin Fears, H. Ferres, Martin Hibbs, R. Standring	8
20	Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin 1985 ·Biochemical Journal ·Robin Fears, Martin Hibbs, Richard A. Smith	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact